76 related articles for article (PubMed ID: 35116478)
1. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
[TBL] [Abstract][Full Text] [Related]
2. Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer.
Tang R; Tong J; Shang S; Li G; Sun F; Guan X; Yang J
Biochem Genet; 2024 Apr; ():. PubMed ID: 38683465
[TBL] [Abstract][Full Text] [Related]
3. Identification of crucial genes and pathways associated with prostate cancer in multiple databases.
Guo H; Zhang Z; Wang Y; Xue S
J Int Med Res; 2021 Jun; 49(6):3000605211016624. PubMed ID: 34082608
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value.
Hong S; Fu N; Sang S; Ma X; Sun F; Zhang X
J Ovarian Res; 2024 Mar; 17(1):64. PubMed ID: 38493179
[TBL] [Abstract][Full Text] [Related]
5. Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.
Xu T; Dong M; Wang Z; Li H; Li X
Cancer Manag Res; 2020; 12():5773-5786. PubMed ID: 32765080
[TBL] [Abstract][Full Text] [Related]
6. Role of the KRT7 Biomarker in Immune Infiltration and Paclitaxel Resistance in Ovarian.
Wang S; Li H; Li M; Liu X; Yu S; Huang H; Wang X
Altern Ther Health Med; 2023 Jul; 29(5):132-140. PubMed ID: 37023314
[TBL] [Abstract][Full Text] [Related]
7. Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis.
Pei L; Li Y; Gu H; Wang S; Wu W; Fan S; Shi X; Si X
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38773061
[TBL] [Abstract][Full Text] [Related]
8. Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis.
Zhao H; Jiang A; Yu M; Bao H
J Cell Biochem; 2020 Dec; 121(12):4908-4921. PubMed ID: 32692884
[TBL] [Abstract][Full Text] [Related]
9. NDC80 Kinetochore Complex Serves as a Potential Prognostic Predictor and Correlates with Immune Infiltrates in Epithelial Ovarian Cancer Patients.
Yu X; Pan M; Jiang L; Liu K
Int J Gen Med; 2024; 17():1789-1805. PubMed ID: 38711823
[TBL] [Abstract][Full Text] [Related]
10.
Zhang L; Wu X; Fan X; Ai H
Comb Chem High Throughput Screen; 2023; 26(14):2487-2501. PubMed ID: 36856181
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
[TBL] [Abstract][Full Text] [Related]
12. Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses.
Cao W; Wang C; Zhang Y; Yang J; Luo X; Zhao Y; Wu M; Cheng S; Wang Y
Eur J Med Res; 2024 Mar; 29(1):166. PubMed ID: 38475882
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (
Karim MA; Samad A; Adhikari UK; Kader MA; Kabir MM; Islam MA; Hasan MN
Biomedicines; 2020 Jan; 8(2):. PubMed ID: 31973134
[TBL] [Abstract][Full Text] [Related]
14. Low expression of ACOT13 predicts poor prognosis and immunotherapy outcome in ovarian cancer.
Xie T; Liu T; Wu L; Yi N
Am J Transl Res; 2024; 16(4):1424-1441. PubMed ID: 38715807
[TBL] [Abstract][Full Text] [Related]
15. Identification of different subtypes of ovarian cancer and construction of prognostic models based on glutamine-metabolism associated genes.
Yaqing X; Yang G; Linlin Y; Youqing R; Henghui Y; Ping Y; Hongying Y; Shaojia W
Heliyon; 2024 Mar; 10(6):e27358. PubMed ID: 38509907
[TBL] [Abstract][Full Text] [Related]
16. Multi‑dimensional analysis reveals NCKAP5L is a promising biomarker for the diagnosis and prognosis of human cancers, especially colorectal cancer.
Sha Y; Liang W; Mo C; Hou X; Ou M
Oncol Lett; 2024 Feb; 27(2):53. PubMed ID: 38192666
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics prognostic signatures of IPO11 mRNA expression and clinical outcomes in colorectal cancer using bioinformatics approaches.
Aljahdali MO; Molla MHR
Health Inf Sci Syst; 2023 Dec; 11(1):57. PubMed ID: 38028961
[TBL] [Abstract][Full Text] [Related]
18. FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas.
Raman P; Purwin T; Pestell R; Tozeren A
Cancer Inform; 2015; 14():113-9. PubMed ID: 26494976
[TBL] [Abstract][Full Text] [Related]
19. FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m
Tan L; Wang S; Huang S; Tie Y; Sai N; Mao Y; Zhao S; Hou Y; Dou H
Cancer Sci; 2024 Apr; 115(4):1224-1240. PubMed ID: 38403332
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
